Ethinylestradiol 50 mcg + Lynestrenol 2.5 mg is indicated in oral contraception, prevention of pregnancy
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Ethinylestradiol + Lynestrenol is a combined oral contraceptive used by women to prevent unwanted pregnancy. It is also employed in the treatment of irregular menstrual cycles and moderate to severe acne. The medication contains Ethinylestradiol and Lynestrenol, which function as ovulation inhibitors and modify cervical secretions to create a hostile environment for sperm. Additionally, Lynestrenol suppresses gonadotropin production and inhibits uterine cell growth, further contributing to its contraceptive effects.
Caution should be exercised while consuming alcohol with Regumen as there may be a minor interaction.
Regumen is not recommended for use during pregnancy. Stop taking Regumen and consult a doctor immediately if you get pregnant while taking Regumen.
Regumen may affect the production of breast milk. Other forms of contraception are advised as long as breastfeeding continues. Please consult the doctor.
Regumen is unlikely to affect driving ability. However, Regumen may cause dizziness. Drive only if you are alert.
Regumen should be used with caution in those with kidney disease. Please consult your doctor if you have any concerns. Your doctor will prescribe only if the benefits outweigh the risks.
Regumen should be used with caution in those with liver disease. Please consult your doctor if you have any concerns. Your doctor will prescribe only if the benefits outweigh the risks.
Contraception
Lynestrenol + Ethinyl Estradiol is a combination that contains 2 female hormones: Lynestrenol and Ethinyl Estradiol. It prevents pregnancy by stopping the sperm cells from entering the uterus and preventing the development of the female egg.
Nausea, vomiting, Cholestatic jaundice, Thrombosis, BP rise, Rash, Headache, migraine, mood change, Breast tenderness, pain, enlargement, secretion.
Ethinylestradiol & Lynestrenol are indicated in oral contraception, and prevention of pregnancy.
Ethinylestradiol, similar to oestradiol, is responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. It inhibits the anterior pituitary by negative feedback effect and causes capillary dilation, fluid retention, and protein anabolism. Lynestrenol, a progestogen structurally related to norethisterone, may be used alone or as the progestogenic component of some oral contraceptives.
The pill is to be taken daily, preferably after the evening meal or at bedtime, at about the same time every day. Each subsequent pack is started on the day after the current pack is completed. Continue taking one pill each day. Menstruation may start while taking the brown pills; do not discontinue taking them. When the patient wishes for the period to begin, stop tablet taking. Some breakthrough bleeding or spotting may occur while using the second pack. Start with the next pack after the usual 7-day red inactive pill interval. Follow the advice concerning the Management of Missed Pills in case of vomiting.
CYP1A2 and CYP3A4 inducers such as aminoglutethimide, carbamazepine, phenobarbital, and rifampin may decrease the effects of estradiol. There may be an enhanced effect of hydrocortisone and prednisolone when used together. Altered anticoagulant effect when used with dicoumarol. Antibiotics (ampicillin, tetracycline, sulphonamides, and chloramphenicol) can cause intermenstrual bleeding or failure of contraception. Reduced efficacy of antihypertensives or hypoglycaemic drugs. Increased metabolism and subsequent reduction in efficacy with enzyme-inducing agents e.g., carbamazepine, griseofulvin, phenobarbital, phenytoin, and rifampicin. Adjustment in antidiabetic dose may be required. May increase plasma levels and toxicity of ciclosporin.
Pregnancy, Cardiovascular diseases, Thromboembolic disorders, Severe hypertension, Severe liver disease, Known or suspected estrogen-dependent tumor, Endometrial hyperplasia.
Pregnancy Category X. Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in the use of the drug in pregnant women clearly outweigh potential benefits.
Some medications may interfere with the efficacy of the pill. Contact your doctor if you are taking any drugs, such as antibiotics, rifampicin, or medicines for seizures. You may have to use another method of contraception during this time.
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.